Science
Jürg Gertsch: “There is definitely a growing interest in cannabis-related research”
The International Medical Cannabis Conference Bern (IMCCB), organised by Professors Jürg Gertsch and Rudolf Brenneisen, aims to bring together physicians, researchers, industry professionals and patients to discuss the current state and future of medical cannabis. In anticipation of this important event, we spoke to Prof. Jürg Gertsch, who told us about the main highlights of the conference, which takes place this week, on 13 and 14 February, at the University of Bern, Switzerland.
In this interview, Jürg Gertsch tells us a little about the main presentations that will take place at the conference, emphasizing the complexity of the endocannabinoid system, the challenges in standardizing cannabis-based medicines, due to the variability in THC and CBD content and the importance of certificates of analysis (CoA).
Gertsch also discusses the potential of minor cannabinoids and terpenes, the impact of irradiation on cannabis flowers, and the importance of precision medicine and individualized endocannabinoid profiles. We end the conversation with some thoughts on the pilot projects underway in Switzerland, which are exploring the recreational use of cannabis in four regions.
You can watch the full interview on our YouTube channel:
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.
The Spanish Pain Society will discuss cannabis-based medications on January 30th in Madrid.
The Spanish Pain Society is organizing the first "In-person Conference on Cannabis-Based Medicines," to be held in...
Cannabis Europa returns to Paris on February 19th, at a crucial moment for the sector in France.
Cannabis Europa, one of the leading cannabis conferences in Europe, will return to Paris next year...
Michael Sassano: "Approvals can be better streamlined and keep the same rigorous quality standards."
SOMAÍ Pharmaceuticals announced today that it has obtained three Marketing Authorizations (MAs) from Infarmed and...
Spain: Supreme Court accepts pharmacists' appeal against the exclusion of community pharmacies from dispensing cannabis.
The Spanish Supreme Court has accepted the appeal filed by the Consejo General de Colegios de Farmacéuticos (CGCOF) last month...
Infarmed grants three ACMs to SOMAÍ's first medicinal cannabis products in Portugal
Infarmed has granted Marketing Authorizations (MA) to three cannabis-based preparations and substances for the purpose of...
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Thousands of French patients using medicinal cannabis will continue to receive their treatment for the foreseeable future, as...
Brazil: Anvisa bans CBD purchased from Paraguay by the São Paulo Public Administration; Public Prosecutor's Office investigates.
The Brazilian National Health Surveillance Agency (Anvisa) seized a shipment of cannabidiol (CBD) products last November...
Spain includes medicinal cannabis magistral preparations in the National Formulary
The Spanish Ministry of Health has officially approved the inclusion of standardized compounded cannabis (THC and CBD) solutions...
Norway: AROD asks the International Criminal Court to consider drug prohibition a crime against humanity.
The Alliance for Rights-Oriented Drug Policies (AROD), a Norwegian organization advocating for the revision of drug laws, decided to send a...
Relm Insurance and Prohibition Partners release cannabis risk report for emerging and high-growth industries.
Hamilton, Bermuda — January 15, 2026: Relm Insurance (Relm), a leading insurer focused on emerging industries, today launched...
